OR WAIT null SECS
February 28, 2020
Eurofins DiscoverX partners with VelaLabs to enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions.
February 01, 2020
CMOs and CDMOs expanded their services and facilities in 2019 and early 2020.
January 27, 2020
Drug development contract services company PPD announces initial public offering.
December 02, 2019
As regulatory bodies extend the oversight of E&L testing, companies working with drug products need to make provisions on how to best comply with the evolving expectations.
November 22, 2019
New training facilities, laboratories, packaging, gene therapy manufacturing, and biologics manufacturing highlight Thermo Fisher Scientific expansions.
August 02, 2019
CMOs and CDMOs expanded their services and facilities in the summer of 2019.
August 01, 2019
A one-size-fits-all strategy is not the best approach for the development of a chemistry, manufacturing, and controls program.
Using advanced HDX-MS and native MS techniques can improve the identification of potentially successful biologic drugs and de-risk CMC and clinical designs.
Key considerations when searching for an analytical service provider include workflow, hardware, and regulatory support.
July 30, 2019
Cambrex has revealed that it is expanding its solid form screening and crystallization process development facility in Edinburgh, Scotland.